CIDRAP newsletters options
The Coalition for Epidemic Preparedness Innovations (CEPI) yesterday announced that it has awarded a contract worth as much as $19 million to Oxford University and Janssen Vaccines to advance the development and manufacture of a vaccine against MERS-CoV and do preclinical studies of new vaccines against Lassa and Nipah viruses.
Coverage in kids 4 and younger was 67.8% last season, down 2.2 percentage points.
The data suggest that, for the vast majority of men, Zika RNA is cleared from semen within 4 months.
Whole-genome sequencing could lead to faster, more accurate resistance testing.
A case report today from the Centers for Disease Control and Prevention (CDC) details the detection of a multidrug-resistant fungus in patients from three states.
Flu vaccine uptake in UK seniors has been high in recent flu seasons, but vaccine effectiveness (VE) has been modest in this age-group and the vaccine has been ineffective against the most severe strain, according to a study today in Eurosurveillance.
More than 100 governments, drug firms, and others have already made commitments.
Also, officials report a new case in Beni.
Two other health workers may have had similar exposure after treating the UK's second monkeypox patient.
The US Food and Drug Administration (FDA) today released new draft guidance that spells out when it's appropriate to disclose retail information for recalled products.
Twelve European third-party stakeholders made recommendations for ensuring antibiotic development and the equitable availability and responsible use of effective antibiotics, focusing on new incentives, according to a commentary yesterday in Clinical Infectious Diseases.
The DRC reports 150 confirmed and suspected cases, with 9 cases under investigation.
Duration of antibiotics was cut by 2 days in some cases.
A small single-center UK study has demonstrated that a diagnostics-driven antifungal stewardship (AFS) program was tied to an 89% drop in inappropriate prescribing, according to a study yesterday in the Journal of Antimicrobial Chemotherapy.
A phase 2 study of an adjuvanted subunit vaccine against tuberculosis (TB) in young and middle-aged adults with the latent form of the disease found that it was 54% effective against progression to the active pulmonary form of the disease. An international team led by scientists from GlaxoSmithKline, the vaccine's developer, reported its findings today in the New England Journal of Medicine.
Cases have now reached 149, including 100 fatalities.
The office of New York Governor Andrew Cuomo announced today that the New York State Department of Health (DOH) will partner with ILÚM Health Solutions to develop a research program to detect, track, and manage antibiotic-resistant infections at healthcare facilities across the state.
The Nigeria Centre for Disease Control (NCDC) said today that six suspected monkeypox cases are associated with one of the recent monkeypox illnesses in England, in a report that noted two new confirmed cases in the same Nigerian state as the suspected cases.
The DoD has made only 18 of 35 proposed changes designed to enhance lab security, the report says.
The case is in Tchomia, on Lake Albert, which straddles the DRC-Uganda border.